Oventus are sponsoring upcoming clinical trials using the new generation O2VentTM oral appliance for the treatment of Obstructive Sleep Apnoea.
Breathing Assist Solutions in Brisbane are currently looking for volunteers who suffer from Obstructive Sleep Apnoea to participate in these trials. Places are limited so please call as soon as possible on 1300 416 743 to nominate your interest and find out if you are eligible.
More information on the clinical trial can be found below:
Safety and efficacy of Oventus O2VentTM and the effect of incorporation of an enclosed airway on compliance in patients with obstructive sleep apnoea
ACTRN12616000740493 HREC approval from Bellberry
The O2VentTM is a novel oral appliance for the treatment of snoring and obstructive sleep apnoea. It is the only device with a built in airway that allows patients to breathe through the device.
The primary objectives of this study are to demonstrate:
1. the safety and efficacy of Oventus O2VentTMoral appliance and
2. that the incorporation of an enclosed airway improves comfort and compliance
Participants with mild-moderate OSA or CPAP intolerant severe OSA are eligible to participate.
Participants will be fitted with a customised oral appliance. Sleep studies at baseline will be performed before an acclimatisation period and treatment optimisation with O2VentTM. Additional sleep studies and rhinomanometry will be conducted at the end of 2 weeks of treatment with a) the device airway open and b) device airway closed. Sleep symptoms, usage and comfort will be assessed during this time.
Research is being conducted in Brisbane. Please contact Breathing Assist Solutions on 1300 416 743 for more information.